Cancel
Incyte
Incyte Employees
16 people indexed:
-
Barry P. Flannelly, PharmD, MBA
Executive Vice President and General Manager, North America
87.wsus558qj.37w749.w78@vu0wq4.u41 Sign up to see email5z.j7vz0v75w.k7356s.g0s@261kku.w77 Sign up to see email -
ap@9vlpz8.qvu Sign up to see email
-
49prdkg0@z24b0s.x1q Sign up to see email
-
Christiana Stamoulis
Executive Vice President and Chief Financial Officer
4x4934b2h4@dpp86x.0wv Sign up to see email9bpv55h8qw@z47k2x.djv Sign up to see email -
Denise Brashear
Vice President, Head of Global Communications
1153830pu@55963z.k87 Sign up to see emailf05fklju3@643wuq.lpf Sign up to see email -
Greg Shertzer, PharmD
Associate Director, Investor Relations
8j1lx6038@9lf4da.2ff Sign up to see email5vl326px3@3jx02b.79b Sign up to see email -
340kslrw4@22rf8f.241 Sign up to see email
-
Jonathan E. Dickinson
Executive Vice President and General Manager, Europe
0f.0wv74a80a@65xqh0.20q Sign up to see email4p.vuqrpl801@bq09lh.5ww Sign up to see email -
Matteo Trotta, MBA
Executive Vice President, General Manager, U.S. Dermatology
0puf8qz.zsq@gqh0kz.627 Sign up to see emailv03195f.vgw@025vps.f1x Sign up to see email -
Michael Morrissey
Executive Vice President and Head of Global Technical Operations
21jd62g67d@hufdl9.a27 Sign up to see emailf4d44zl5x8@3abzbu.jb6 Sign up to see email -
Pablo J. Cagnoni, M.D.
President, Head of Research and Development
0u.372zqv2.0.4@2sx64u.w4h Sign up to see email44.18usfk1.3.v@krll7x.bv8 Sign up to see email -
lz.2g4gx@10g9q3.2bx Sign up to see email
-
Sheila A. Denton, J.D.
Executive Vice President and General Counsel
xv.9p8v77.2.x@12f86w.xv2 Sign up to see emailqq.pkzbgv.3.q@k5gp4g.bw8 Sign up to see email -
Steven H. Stein, M.D.
Executive Vice President and Chief Medical Officer
wv.8z9jw.9.8@7v0fr7.f6b Sign up to see emailj7.bww6b.g.5@2kj97r.93g Sign up to see email -
Vijay Iyengar, M.D.
Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy
8bx22bs7.9.u@x5w751.2qj Sign up to see emailw7szh66h.5.u@bu8zwh.jkl Sign up to see email -
Xiaozhao Wang, Ph.D.
Associate Vice President, Head of Medicinal Chemistry
9szku.z9.5@z6ql4f.q6q Sign up to see emails2u63.1l.b@671ubk.813 Sign up to see email
Incyte's Specializations
Incyte specializes in biopharmaceutical solutions aimed at addressing unmet medical needs. The company focuses on scientific excellence, particularly in the fields of oncology and dermatology. By leveraging cutting-edge research and development, Incyte has developed a robust portfolio of treatments that target a variety of medical conditions. Their commitment to innovation ensures that they remain at the forefront of developing new therapies that can significantly improve patient outcomes.
Incyte's Global Operations
Incyte operates on a global scale, with its headquarters located in Wilmington, DE, USA, and its European headquarters in Morges, Switzerland. The company has established a strong international presence with additional locations in countries such as Denmark, Italy, Spain, United Kingdom, Finland, Japan, Sweden, Austria, France, the Netherlands, Switzerland, Canada, Germany, Norway, and Portugal. This extensive network allows Incyte to efficiently manage and expand its operations while ensuring that patients worldwide have access to its innovative treatments.
Incyte's Products
Incyte offers a diverse portfolio of products designed to treat various medical conditions and diseases. Their product lineup includes treatments that have been developed through rigorous scientific research and clinical trials. These products are aimed at providing effective solutions for patients dealing with complex health issues, particularly in oncology and dermatology. Incyte's focus on developing high-quality, effective treatments underscores their dedication to improving patient health and quality of life.
Incyte's Patient Support Programs
Incyte is committed to supporting patients through a range of resources and programs. These initiatives are designed to provide patients with the necessary information and assistance to manage their health conditions effectively. Incyte's support programs often include educational materials, financial assistance, and access to healthcare professionals who can offer guidance and support. By prioritizing patient needs, Incyte aims to enhance the overall treatment experience and ensure better health outcomes.
Incyte's Corporate Responsibility
Incyte is deeply committed to corporate responsibility, with initiatives focused on patients, the community, and the environment. The company actively engages in programs that aim to make a positive impact, such as environmental sustainability efforts, community outreach, and ethical business practices. Incyte also fosters a culture of inclusion and diversity within the workplace, recognizing that a diverse workforce contributes to innovative thinking and better problem-solving. These efforts reflect Incyte's dedication to conducting business in a socially responsible and ethically sound manner.
Report inaccurate information
Report inaccurate information
